Nicole Vitullo, Director at Esperion Therapeutics, Inc. (ESPR), sold 1,134,199 shares at $44.66 ($686K) on 2019-03-19, disclosed to the SEC on 2019-03-21.
Open-market sale of $686k ESPR by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 1,101,080 | $0 | 0.0% |
| 2 | $44.66 | 13,629 | $609K | 88.8% |
| 3 | $45.25 | 1,700 | $77K | 11.2% |
| 4 | $0.00 | 17,790 | $0 | 0.0% |
| Total | $0.60 avg | 1,134,199 | $686K | 100% |
| Filing → |
| ESPR | SELL | 2017-12-08 | $502K | — | Filing → |
| CLCD | SELL | 2016-05-02 | $2.1M | — | Filing → |
| EVOK | SELL | 2016-04-27 | $415 | — | Filing → |